Pancreatic cancer: from molecular pathogenesis to targeted therapy

Cancer Metastasis Reviews
Alexios S StrimpakosKostas N Syrigos

Abstract

Pancreatic cancer is a deadly malignancy with still high mortality and poor survival despite the significant advances in understanding, diagnosis, and access to conventional and novel treatments. Though cytotoxic chemotherapy based on the purine analogue gemcitabine remains the standard approach in adjuvant and palliative setting the need for novel agents aiming at the main pathophysiological abnormalities and molecular pathways involved remains soaring. So far, evidence of clinical benefit, though small, exists only from the addition of the targeted agent erlotinib on the standard gemcitabine chemotherapy. Apart from the popular monoclonal antibodies and small molecules tyrosine kinase inhibitors, other novel compounds being tested in preclinical and clinical studies target mTOR, NF-kappaB, proteasome and histone deacetylase. These new drugs along with gene therapy and immunotherapy, which are also under clinical evaluation, may alter the unfavorable natural course of this disease. In this review we present the main pathophysiological alterations met in pancreatic cancer and the results of the florid preclinical and clinical research with regards to the targeted therapy associated to these abnormalities.

References

Dec 1, 1991·British Journal of Cancer·C M BartonR C Williamson
Aug 25, 1988·Nucleic Acids Research·V T SmitJ L Bos
Feb 1, 1988·The American Journal of the Medical Sciences·R HansenT Anderson
Oct 1, 1995·The Surgical Clinics of North America·J A LumadueR H Hruban
Feb 1, 1995·Japanese Journal of Cancer Research : Gann·S NakamoriT Sekiya
Oct 1, 1993·Human Pathology·Y YamanakaM Korc
Apr 15, 1994·International Journal of Cancer. Journal International Du Cancer·M A HollingsworthD R Mack
Nov 1, 1995·Current Opinion in Oncology·S W Lowe
Apr 16, 1996·Proceedings of the National Academy of Sciences of the United States of America·J Q ChengJ R Testa
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H A BurrisD D Von Hoff
Apr 1, 1997·International Journal of Pancreatology : Official Journal of the International Association of Pancreatology·S T DerghamF H Sarkar
Jun 1, 1997·International Journal of Pancreatology : Official Journal of the International Association of Pancreatology·S T DerghamF H Sarkar
Mar 3, 1998·Biochemical and Biophysical Research Communications·M P LutzG Adler
Jun 6, 1998·Science·J R HoweL A Aaltonen
Oct 28, 1998·Journal of the National Cancer Institute·M M Taketo
Oct 30, 1998·Frontiers in Bioscience : a Journal and Virtual Library·G HeywoodH J Wanebo
Dec 16, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K FujimotoM Imamura
Apr 3, 1999·British Journal of Cancer·N IkedaM Miyake
Jun 11, 1999·American Journal of Clinical Oncology·A RosemurgyH Rasmussen
Aug 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·I Schwarte-WaldhoffW Schmiegel
Feb 22, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F A EskensUNKNOWN European Organization for Research and Treatment of Cancer Early Clinical Studies Group
Mar 20, 2001·Critical Reviews in Oncology/hematology·X D YangC G Davis
May 2, 2001·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·H G HotzO J Hines
May 2, 2001·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·P BüchlerO J Hines
May 9, 2001·The Journal of Surgical Research·S A ShahM P Callery
May 9, 2001·The American Journal of Surgical Pathology·R H HrubanG J Offerhaus
Jun 16, 2001·Journal of Cellular Biochemistry·S A ShahM P Callery
Jul 27, 2001·Journal of Cancer Research and Clinical Oncology·M P EbertP Malfertheiner
Aug 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S R BramhallUNKNOWN Marimastat Pancreatic Cancer Study Group
Aug 23, 2001·The Journal of Surgical Research·R J BoldD J McConkey
Oct 5, 2001·American Journal of Clinical Oncology·H SafranU Tantravahi

❮ Previous
Next ❯

Citations

Jan 30, 2010·Cancer Metastasis Reviews·Georgios S Papaetis, Kostas N Syrigos
Jan 12, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sonia Tusell WennierGrant McFadden
Aug 5, 2010·Molecular Cancer Therapeutics·Nagathihalli S NagarajNipun B Merchant
Feb 7, 2013·Cancer Discovery·Vishal KothariChandan Kumar-Sinha
Sep 11, 2012·BMC Cancer·Carole M TactacanUNKNOWN Australian Pancreratic Genome Initiative
Aug 13, 2009·World Journal of Gastroenterology : WJG·Guang YangZheng-Jun Qiu
Oct 5, 2010·Metal-based Drugs·Nektaria MakriliaMuhammad Wasif Saif
Apr 19, 2011·Molecular Cancer Research : MCR·Seung-Hee LeePamela Itkin-Ansari
Oct 16, 2009·Expert Review of Anticancer Therapy·R Pamela Mackenzie, A David McCollum
Sep 1, 2009·Expert Review of Clinical Pharmacology·Jia LiMuhammad W Saif
Jun 4, 2013·Vaccine·Winnie M ChanGrant McFadden
Nov 14, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jheelam BanerjeeHildegard M Schuller
Dec 6, 2011·Cancer Letters·Si ShiXianjun Yu
Oct 13, 2009·European Journal of Internal Medicine·Nektaria MakriliaKostas Syrigos
Apr 21, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Arne WestgaardIvar P Gladhaug
Oct 16, 2012·Aging Cell·Willemijn M PasstoorsPieternella E Slagboom
Dec 23, 2009·International Journal of Cancer. Journal International Du Cancer·Ruth ChuSylvia Fong
Jul 2, 2010·British Journal of Pharmacology·Gabriela B IwanskiH Phillip Koeffler
Jan 1, 2011·Cancers·Konstantinos Karapanos, Iakovos N Nomikos
Apr 17, 2018·International Journal of Molecular Sciences·Jong Kook ParkThomas D Schmittgen
Aug 25, 2017·Expert Opinion on Biological Therapy·Fang Liu, Muhammad Wasif Saif
Sep 13, 2019·Cell Communication and Signaling : CCS·Jiang-Jiang QinWei-Dong Zhang
Nov 10, 2009·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Georgios S Papaetis, Kostas N Syrigos
Mar 1, 2013·Molecular Medicine Reports·Yi-Qun HuJing-Ping Zhou
Mar 17, 2018·Naunyn-Schmiedeberg's Archives of Pharmacology·Mаhmoud YounsRehab Kamel
Apr 2, 2016·Molecular Medicine Reports·Jin LongChunlin Ge
Oct 13, 2011·Molecular Cancer Research : MCR·Benjamin A KatchmanDouglas F Lake
Apr 5, 2013·Molecular Cancer Research : MCR·Huei-Ting SuKuang-Hung Cheng
Apr 17, 2020·Current Pharmaceutical Biotechnology·Saleh A AlmatroodiArshad Husain Rahmani
Jan 6, 2011·Archives of Pathology & Laboratory Medicine·Anne Igbokwe, Dolores H Lopez-Terrada

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved